Showing results (1821-1830 of 1,985) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|May 3, 2014
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trialPooja Khatri, Sharon D Yeatts, Mikael Mazighi, et al.The Lancet. Neurology|October 4, 2016
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association studyJoanne Trinh, Emil K Gustavsson, Carles Vilariño-Güell, et al.The Lancet. Neurology|March 25, 2017
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studiesDaryl J Wile, Pankaj A Agarwal, Michael Schulzer, et al.The Lancet. Neurology|June 12, 2012
Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trialMichel Baulac, Martin J Brodie, Anna Patten, et al.The Lancet. Neurology|November 22, 2012
Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trialVincent J J Odekerken, Teus van Laar, Michiel J Staal, et al.The Lancet. Neurology|September 19, 2014
The neuro-ophthalmology of head traumaRachel E Ventura, Laura J Balcer, Steven L GalettaThe Lancet. Neurology|September 19, 2014
Epidemiology, causes, and treatment of epilepsy in sub-Saharan AfricaAwa Ba-Diop, Benoît Marin, Michel Druet-Cabanac, et al.The Lancet. Neurology|August 4, 2014
Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studiesThe Lancet. Neurology|July 18, 2014
Neurofibromatosis type 1: a multidisciplinary approach to careAngela C Hirbe, David H GutmannThe Lancet. Neurology|December 3, 2013
The genetic basis of DOORS syndrome: an exome-sequencing studyPhilippe M Campeau, Dalia Kasperaviciute, James T Lu, et al.Pageof 199